Page 1 of Clinical Trials for Galectin Therapeutics Inc. [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
Last Updated: March 13, 2012
Condition(s): Colorectal Cancer
2
Terminated
Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
Last Updated: March 13, 2012
Condition(s): Cancer of the Bile Duct; Gallbladder Cancer
3
Terminated
GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
Last Updated: March 5, 2012
Condition(s): Colorectal Cancer
4
Completed
Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors
Last Updated: March 9, 2012
Condition(s): Colorectal Cancer; Lung Cancer; Breast Cancer; Head and Neck Cancer; Prostate Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Galectin+Therapeutics+Inc.

Page 1 of Clinical Trials for Galectin Therapeutics Inc. [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About